{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:26:44Z","timestamp":1793327204840,"version":"4.5.0"},"reference-count":28,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The effectiveness of rabies vaccines is conventionally determined by serological testing. In addition to this assessment of humoral immunity, cellular immunity could help assess effectiveness and protection through a broad range of parameters. Therefore, this study aimed to systematically review all literature on the kinetics and composition of the cellular immune response to rabies vaccination in humans. A total of 1360 studies were identified in an extensive literature search. Twenty studies were selected for inclusion. In a primary response, plasma cells are detectable from day 7 to day 14, peaking at day 10. Memory B-cells appear from day 10 up to at least day 28. After revaccination, natural killer (NK) cells are the first detectable cellular parameters. Further research is required to assess cellular parameters in relation to long-term (serological) immunity. This review was registered in the International Prospective Register of Systematic Reviews (PROSPERO) under registration number CRD42019134416.<\/jats:p>","DOI":"10.3390\/vaccines7030110","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T11:26:34Z","timestamp":1568201194000},"page":"110","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The Cellular Immune Response to Rabies Vaccination: A Systematic Review"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-2874","authenticated-orcid":false,"given":"Lisanne A.","family":"Overduin","sequence":"first","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, The Netherlands"},{"name":"Department of Infectious Diseases, Leiden University Medical Center, 2333ZA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J.M.","family":"van Dongen","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardus G.","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Center, 2333ZA Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","article-title":"Current status of rabies and prospects for elimination","volume":"384","author":"Fooks","year":"2014","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hampson, K., Coudeville, L., Lembo, T., Sambo, M., Kieffer, A., Attlan, M., Barrat, J., Blanton, J.D., Briggs, D.J., and Cleaveland, S. (2015). Estimating the Global Burden of Endemic Canine Rabies. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003786"},{"key":"ref_3","unstructured":"WHO (2019, June 16). Rabies Vaccines: WHO Position Paper. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272371\/WER9316.pdf?ua=1."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Denis, M., Knezevic, I., Wilde, H., Hemachudha, T., Briggs, D., and Knopf, L. (2018). An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route. Vaccines.","DOI":"10.1016\/j.vaccine.2018.11.072"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/cid\/ciy420","article-title":"Rabies Antibody Response After Booster Immunization: A Systematic Review and Meta-analysis","volume":"67","author":"Langedijk","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","unstructured":"WHO (2019, June 20). Rabies Working Group Report, SAGE Meeting of October 2017. Available online: http:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/1_Background_paper_WG_RABIES_final.pdf?ua=1."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., and Altman, D.G. (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Sterne, J.A., Hern\u00e1n, M.A., Reeves, B.C., Savovi\u0107, J., Berkman, N.D., Viswanathan, M., Henry, D., Altman, D.G., Ansari, M.T., and Boutron, I. (2016). ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ, 355.","DOI":"10.1136\/bmj.i4919"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.4049\/jimmunol.131.3.1234","article-title":"Induction of antigen-specific antibody response in human peripheral blood lymphocytes in vitro by a dog kidney cell vaccine against rabies virus (DKCV)","volume":"131","author":"UytdeHaag","year":"1983","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/jvi.56.2.426-433.1985","article-title":"Amplification of rabies virus-induced stimulation of human T-cell lines and clones by antigen-specific antibodies","volume":"56","author":"Celis","year":"1985","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4049\/jimmunol.136.2.692","article-title":"Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-gamma","volume":"136","author":"Celis","year":"1986","journal-title":"J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1128\/jvi.62.9.3128-3134.1988","article-title":"Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients","volume":"62","author":"Celis","year":"1988","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1099\/0022-1317-70-6-1513","article-title":"Rabies Virus-specific Human T Cell Clones Provide Help for an in vitro Antibody Response against Neutralizing Antibody-inducing Determinants of the Viral Glycoprotein","volume":"70","author":"Bunschoten","year":"1989","journal-title":"J. Gen. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.171.1.19","article-title":"Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus","volume":"171","author":"Ueki","year":"1990","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2249.1991.tb05709.x","article-title":"T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination","volume":"85","author":"Herzog","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0168-1702(92)90032-5","article-title":"Nucleocapsid specific T and B cell responses in humans after rabies vaccination","volume":"24","author":"Herzog","year":"1992","journal-title":"Virus Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1099\/0022-1317-74-8-1539","article-title":"Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein","volume":"74","author":"Langedijk","year":"1993","journal-title":"J. Gen. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/clin.1994.1088","article-title":"Long-Term Humoral and Cellular Immunity after Vaccination with Cell Culture Rabies Vaccines in Man","volume":"71","author":"Thraenhart","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/CDLI.8.5.880-883.2001","article-title":"Human Lymphocyte Proliferation Responses following Primary Immunization with Rabies Vaccine as Neoantigen","volume":"8","author":"Ghaffari","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/B:JOCI.0000010429.36461.6b","article-title":"Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man","volume":"23","author":"Brinkman","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.exger.2003.11.018","article-title":"T cells from elderly persons respond to neoantigenic stimulation with an unimpaired IL-2 production and an enhanced differentiation into effector cells","volume":"39","author":"Gomez","year":"2004","journal-title":"Exp. Gerontol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10875-006-9044-0","article-title":"Detection of Cellular Immunity to Rabies Antigens in Human Vaccinees","volume":"26","author":"Moore","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-007-9120-0","article-title":"Resetting the Adaptive Immune System After Autologous Stem Cell Transplantation: Lessons from Responses to Vaccines","volume":"27","author":"Brinkman","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1182\/blood-2009-03-211052","article-title":"Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans","volume":"114","author":"Pulickal","year":"2009","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1016\/j.vaccine.2009.03.027","article-title":"Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus","volume":"27","author":"Sirikwin","year":"2009","journal-title":"Vaccines"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.4049\/jimmunol.1000844","article-title":"NK cells as effectors of acquired immune responses: Effector CD4+ T cell-dependent activation of NK cells following vaccination","volume":"185","author":"Horowitz","year":"2010","journal-title":"J. Immunol."},{"key":"ref_27","unstructured":"Vejpongsa, P., Leelasinjaroen, P., Sodsai, P., Hirankarn, N., and Tantawichien, T. (2011, January 7\u201310). Increasing CD4+CD25hiFoxP3+ regulatory T-cells in subjects after repeated booster doses of rabies vaccination. Proceedings of the 21st ECCMID\/27th ICC, Milan, Italy. P2215."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7774\/cevr.2015.4.1.68","article-title":"Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes","volume":"4","author":"Venkataswamy","year":"2015","journal-title":"Clin. Exp. Vaccine Res."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/7\/3\/110\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:18:57Z","timestamp":1760188737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/7\/3\/110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,11]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["vaccines7030110"],"URL":"https:\/\/doi.org\/10.3390\/vaccines7030110","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,11]]}}}